Description générale
Emtricitabine + tenofovir is a fixed-dose combination of nucleotide/nucleoside analog reverse-transcriptase inhibitors (NRTIs) used to prevent and treat HIV/AIDS.
INN
Emtricitabine + tenofovir
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2007
(TRS
946)
pour
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
Ajouté en 2017
(TRS
1006)
pour
Contact with or exposure to human immunodeficiency virus
Wikipédia
DrugBank
Recommandations
Section
Fixed-dose combinations of antiretrovirals
- Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)